30 related articles for article (PubMed ID: 12505322)
21. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
Peter Guengerich F; Chun YJ; Kim D; Gillam EM; Shimada T
Mutat Res; 2003; 523-524():173-82. PubMed ID: 12628515
[TBL] [Abstract][Full Text] [Related]
23. Genetically engineered bacterial cells and applications.
Waterman MR; Jenkins CM; Pikuleva I
Toxicol Lett; 1995 Dec; 82-83():807-13. PubMed ID: 8597146
[TBL] [Abstract][Full Text] [Related]
24. Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis.
Josephy PD
Toxicology; 2002 Dec; 181-182():255-60. PubMed ID: 12505321
[TBL] [Abstract][Full Text] [Related]
25. Development and progress for three decades in
Oda Y
Genes Environ; 2016; 38():24. PubMed ID: 27980699
[No Abstract] [Full Text] [Related]
26. Use of heterologously-expressed cytochrome P450 and glutathione transferase enzymes in toxicity assays.
Guengerich FP; Wheeler JB; Chun YJ; Kim D; Shimada T; Aryal P; Oda Y; Gillam EM
Toxicology; 2002 Dec; 181-182():261-4. PubMed ID: 12505322
[TBL] [Abstract][Full Text] [Related]
27. New applications of bacterial systems to problems in toxicology.
Guengerich FP; Gillam EM; Shimada T
Crit Rev Toxicol; 1996 Sep; 26(5):551-83. PubMed ID: 8891430
[TBL] [Abstract][Full Text] [Related]
28. Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
Rendic SP; Guengerich FP
Arch Toxicol; 2021 Feb; 95(2):395-472. PubMed ID: 33459808
[TBL] [Abstract][Full Text] [Related]
29. Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: an update and practical considerations.
Kranendonk M; Laires A; Rueff J; Estabrook WR; Vermeulen NP
Crit Rev Toxicol; 2000 May; 30(3):287-306. PubMed ID: 10852498
[TBL] [Abstract][Full Text] [Related]
30. Genetically engineered cells stably expressing cytochrome P450 and their application to mutagen assays.
Sawada M; Kamataki T
Mutat Res; 1998 Aug; 411(1):19-43. PubMed ID: 9675235
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
